Bristol-Myers strengthens blood thinner warning
297975
Bristol-Myers Squibb has strengthened its warning about the risk of possible fatal bleeding linked to its blood thinner drug, Coumadin, adding a black box to its label, U.S. health officials said on Friday.
512744
Eli Lilly and Co  said Friday it added a warning to the label of its attention deficit/hyperactivity disorder medicine, advising patients with jaundice or a liver injury to stop taking the treatment.
377570
Certain low-dose birth control pills increase a woman's risk of a potentially deadly blood clot more than others and should be pulled off the market, a consumer group said Tuesday.
93502
Company warns Remicade may up risk of lymphoma, label changed for second time to reflect hazards. NEW YORK  - Johnson &amp; Johnson is warning doctors that patients taking its rheumatoid arthritis drug
606616
Responding to continuing criticism about its warning policies, the Food and Drug Administration said Friday it will strengthen its system for reviewing the safety of drugs already on the market.
722285
WASHINGTON - The Food and Drug Administration on Tuesday warned consumers not to buy or use Actra-Rx or Yilishen because the supplements contain an ingredient that could lower blood pressure to unsafe levels.
728273
Although a U.S. judge has halted  continued shipments of a generic form of Bristol-Myers Squibb  Co.'s  best-selling drug, analysts on Friday cautioned  that huge supplies already on the market would hurt the  company's earnings in 2006 and 2007.
545405
An updated analysis of data from studies of anemia drugs used with cancer treatments showed that they increase risk of death and blood clots, an industry newsletter reported on Friday.
254728
A panel recommended that doctors and patients be given stronger warnings about the dangers associated with the use of drug-coated stents.
602585
Bristol-Myers announces new data for one of its top compounds.
372735
Companies that make drugs to treat attention deficit hyperactivity disorder must take extra steps to alert patients to possible cardiovascular and psychiatric risks, U.S. health officials said on Wednesday.
624263
Eli Lilly and Co LLY.N said Friday  it added a warning to the label of its attention  deficit/hyperactivity disorder medicine, advising patients with  jaundice or a liver injury to stop taking the treatment.
187963
Johnson & Johnson's Ortho Evra   contraceptive patch will come with a new warning about a study   suggesting users could face twice the risks of blood clots   compared with birth control pills, the company and U.S.   regulators said on Wednesday.
285787
A drug used to limit blood loss while patients undergo coronary-artery bypass surgery also carries a higher five-year risk of death than cheaper generic alternatives, a researcher said on Tuesday.
30572
After two highly publicized incidents questioning the safety of some of the biggest selling prescription medicines, the Food and Drug Administration said yesterday it is moving to strengthen its safety monitoring efforts.
226791
A court ruling upholding the  patent on blockbuster blood-thinning drug Plavix has reignited  talk France&#39;s Sanofi-Aventis  will bid for its smaller  U.S. partner Bristol-Myers Squibb Co. .
180961
Bristol-Myers Squibb  has strengthened its warning about the risk of possible fatal bleeding linked to its blood thinner drug, Coumadin, adding a black box to its label, U.S. health officials said on Friday.